Cetohexazine

This classification denotes a sedative and hypnotic with the molecular formula C6H8N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NS7PP85V4C, chemically known as 4,6-dimethyl-3(2h)-pyridazinone. but generally known as cetohexazine, which bears US NIH Compound Identifier 193965. European Medicines Agency schedules Cetohexazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07454MIG. The term CETOHEXAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). CETOHEXAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cetohexazine under HS 29339990 and SITC 51577. As of Q4 2014, CETOHEXAZINE remains the US FDA Preferred Term for this commodity. Cetohexazine bears US NLM identifiers UMLS ID C2699166 and NCI Concept Code C77246. SMILES: O=C1[NH]NC(CC1C)C.